Search results
Showing 8026 to 8040 of 9009 results
Nivolumab for treating relapsed or refractory diffuse large B-cell lymphoma [ID986]
Discontinued Reference number: GID-TA10140
Discontinued Reference number: GID-TA10155
In development Reference number: GID-TA10589 Expected publication date: TBC
ADI-PEG 20 for previously treated hepatocellular carcinoma [ID1025]
Discontinued Reference number: GID-TA10259
Nivolumab with radiation therapy for previously untreated glioblastoma multiforme [ID1562]
Discontinued Reference number: GID-TA10443
Discontinued Reference number: GID-TA10445
Drugs for the treatment of pulmonary arterial hypertension [ID12]
Discontinued Reference number: GID-TAG382
Discontinued Reference number: GID-TAG402
Discontinued Reference number: GID-TAG404
Atrial fibrillation - clopidogrel (in combination with aspirin) [ID95]
Discontinued Reference number: GID-TAG416
Lymphoma (mantle cell) - bendamustine (1st line, with rituximab) [ID609]
Discontinued Reference number: GID-TAG321
New pharmaceutical treatments for non-Alzheimer dementias [ID380]
Discontinued Reference number: GID-TAG369
Discontinued Reference number: GID-TAG371
Palforzia for treating peanut allergy in children aged 1 to 3 [ID6144]
In development Reference number: GID-TA11070 Expected publication date: TBC
Dupilumab for treating chronic spontaneous urticaria in people 12 years and over [ID4055]
In development Reference number: GID-TA11272 Expected publication date: TBC